SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 60 filers reported holding SCPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.83 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,842,415 | -26.4% | 539,665 | +5.3% | 2.28% | -19.8% |
Q2 2023 | $5,220,714 | +12.7% | 512,337 | +0.3% | 2.84% | +25.9% |
Q1 2023 | $4,631,577 | +3.0% | 510,648 | -18.6% | 2.26% | -14.9% |
Q4 2022 | $4,498,121 | +266.0% | 627,353 | +232.8% | 2.66% | +252.6% |
Q3 2022 | $1,229,000 | -31.1% | 188,522 | -43.9% | 0.75% | -28.2% |
Q2 2022 | $1,784,000 | -9.9% | 335,985 | -3.6% | 1.05% | +14.8% |
Q1 2022 | $1,979,000 | +18.5% | 348,425 | +4.7% | 0.91% | +10.5% |
Q4 2021 | $1,670,000 | -16.5% | 332,647 | +10.6% | 0.83% | -8.1% |
Q3 2021 | $2,000,000 | +99.6% | 300,760 | +83.4% | 0.90% | +141.3% |
Q2 2021 | $1,002,000 | -29.6% | 163,994 | -23.4% | 0.37% | -45.9% |
Q1 2021 | $1,423,000 | +65.1% | 214,060 | +31.4% | 0.69% | +1.0% |
Q4 2020 | $862,000 | -34.1% | 162,875 | -7.2% | 0.68% | -36.3% |
Q3 2020 | $1,308,000 | +1.2% | 175,526 | 0.0% | 1.07% | +69.0% |
Q2 2020 | $1,292,000 | +21.5% | 175,526 | +22.2% | 0.64% | -2.9% |
Q1 2020 | $1,063,000 | +51.0% | 143,646 | +15.4% | 0.65% | +89.6% |
Q4 2019 | $704,000 | – | 124,505 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 2,207,009 | $15,713,904 | 7.44% |
5AM Venture Management, LLC | 1,200,647 | $8,548,607 | 2.46% |
Worth Venture Partners, LLC | 539,665 | $3,842,415 | 2.28% |
COWEN AND COMPANY, LLC | 1,795,647 | $12,785,006 | 0.90% |
Orbimed Advisors | 5,559,528 | $39,583,839 | 0.84% |
Rubric Capital Management LP | 2,713,287 | $19,318,603 | 0.72% |
AlphaCentric Advisors LLC | 125,000 | $890,000 | 0.50% |
RTW INVESTMENTS, LP | 3,297,843 | $23,480,642 | 0.50% |
Tejara Capital Ltd | 101,414 | $722,068 | 0.41% |
Leucadia National | 745,550 | $5,308,316 | 0.05% |